Clinical trial
A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk Gastrointestinal Stromal Tumors in NED State Based on Minimal Residual Disease Detection Via Liquid Biopsy
NCT05867901 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk Gastrointestinal Stromal Tumors in NED State Based on Minimal Residual Disease Detection Via Liquid Biopsy
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Suspended
- Start date
- June 1, 2023
- Completion date
- December 31, 2028
- Enrollment
- 66 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.